elhamkhani
/
Test2
/
Login
Register
TriplyDB
Test2
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
1
Q28386699-01E952AC-6B96-49CE-AE10-BA12C2926937
Q28386699-01E952AC-6B96-49CE-AE10-BA12C2926937
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28386699-01E952AC-6B96-49CE-AE10-BA12C2926937
Convergence of nanotechnology and cancer prevention: are we there yet?
P2860
Q28386699-01E952AC-6B96-49CE-AE10-BA12C2926937
BestRank
Statement
http://www.wikidata.org/entity/statement/Q28386699-01E952AC-6B96-49CE-AE10-BA12C2926937
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
e6bbd3f4d75b7f3a1d1a649dd921bb83113a8030
P2860
Preclinical development and clinical translation of a PSMA-targeted docetaxel nanoparticle with a differentiated pharmacological profile.